In the molecular era, NHW individuals have the highest incidence of ADG. However, patients of Chinese-and more broadly East Asian-ethnicity with IDH wild-type glioblastoma exhibit a pronounced and robust survival advantage. This highlights the critical need to consider ancestral diversity in future glioma research to uncover biological mechanisms and improve patient outcomes.
Zhao et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: